Preventive blood thinning drugs linked to reduced risk of death in COVID-19 patients

New study gives hope of eliminating mother-to-baby transmission of HIV
11 February 2021
Tuning the circadian clock, boosting rhythms may be key to future treatments and medicines
12 February 2021

Preventive blood thinning drugs linked to reduced risk of death in COVID-19 patients

Patients given preventive blood thinning drugs (prophylactic anticoagulants) within 24 hours of admission to hospital with COVID-19 are less likely to die compared with those who do not receive them, finds a study published by The BMJ today.

Comments are closed.